triethylenephosphoramide has been researched along with Neuroblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed-Cox, A; Beavis, PA; Cirillo, G; Giorgi, FM; Haber, M; Kavallaris, M; Kimpton, K; Lerra, L; Mayoh, C; Mercatelli, D; Murray, JE; Rouaen, JRC; Saletta, F; Shen, S; Trapani, JA; Valli, E; Vittorio, O; Voli, F | 1 |
1 other study(ies) available for triethylenephosphoramide and Neuroblastoma
Article | Year |
---|---|
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion.
Topics: Animals; B7-H1 Antigen; Brain Neoplasms; Cell Line, Tumor; Chelating Agents; Copper; Copper Transporter 1; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Killer Cells, Natural; Lymphocytes, Tumor-Infiltrating; Mice, Inbred BALB C; Neuroblastoma; Triethylenephosphoramide; Tumor Escape; Xenograft Model Antitumor Assays | 2020 |